Characterization of CAR-T cell factors that contribute to myeloid cell activation
{{output}}
Chimeric antigen receptor (CAR) T cell therapies have shown remarkable success in the treatment of hematologic cancers; however, their use is often accompanied by inflammatory toxicities, including cytokine release syndrome (CRS) and immune effector cell-assoc... ...
